LT
Ladenburg Thalmann Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
76
Coeptis Therapeutics
COEP
$62.4M
|
AH
Aydin Huseynov
| $12.95 | $60 |
363%
upside
| Buy |
22 Sep ‘23
1 year ago |
|
77
WEC Energy
WEC
$34.6B
|
PF
Paul Fremont
| $107.36 | $85 |
21%
downside
| Neutral |
11 Sep ‘23
2 years ago |
|
78
Sonoma Pharmaceuticals
SNOA
$7.51M
|
JC
Jeff Cohen
| $4.57 | $65 |
1,322%
upside
| Buy |
5 Sep ‘23
2 years ago |
|
79
Cognition Therapeutics
CGTX
$212M
|
AH
Aydin Huseynov
| $2.40 | $6 |
150%
upside
| Buy |
14 Aug ‘23
2 years ago |
|
80
NovaBay Pharmaceuticals
NBY
$15.7M
| $2.70 | $133 |
4,826%
upside
| Buy |
11 Aug ‘23
2 years ago |
|
|
81
Southern Company
SO
$99.9B
|
PF
Paul Fremont
| $90.83 | $72 |
21%
downside
| Buy |
9 Aug ‘23
2 years ago |
|
82
WhiteHorse Finance
WHF
$202M
| $8.69 | $13 |
50%
upside
| Neutral |
9 Aug ‘23
2 years ago |
|
|
83
Ardelyx
ARDX
$1.59B
|
MK
Matthew Kaplan
| $6.59 | $8.50 |
29%
upside
| Buy |
3 Aug ‘23
2 years ago |
|
|
SRTA
84
Strata Critical Medical, Inc. Class A Common Stock
SRTA
$327M
|
JH
Jon Hickman
| $4 | $13 |
225%
upside
| Buy |
17 Jul ‘23
2 years ago |
|
|
ATHE
85
Alterity Therapeutics
ATHE
$79.3M
|
AH
Aydin Huseynov
| $5.17 | $10 |
93%
upside
| Buy |
5 Jun ‘23
2 years ago |
|
86
Palisade Bio
PALI
$5.32M
|
AH
Aydin Huseynov
| $0.5709 | $240 |
41,939%
upside
| Buy |
16 May ‘23
2 years ago |
|
87
Ovid Therapeutics
OVID
$88.2M
|
MH
Michael Higgins
| $1.24 | $7 |
465%
upside
| Buy |
2 May ‘23
2 years ago |
|
|
AVDL
88
Avadel Pharmaceuticals
AVDL
$1.49B
|
MK
Matthew Kaplan
| $15.38 | $16 |
4%
upside
| Buy |
2 May ‘23
2 years ago |
|
89
Tempest Therapeutics
TPST
$48.2M
|
AH
Aydin Huseynov
| $10.85 | $182 |
1,577%
upside
| Buy |
28 Apr ‘23
2 years ago |
|
90
Horizon Technology Finance
HRZN
$294M
| $6.91 | $12.50 |
81%
upside
| Buy |
11 Apr ‘23
2 years ago |
|
|
91
PG&E
PCG
$32B
|
PF
Paul Fremont
| $14.56 | $20.50 |
41%
upside
| Buy |
3 Apr ‘23
2 years ago |
|
92
SCYNEXIS
SCYX
$38.4M
|
MH
Michael Higgins
| $0.9171 | $15 |
1,536%
upside
| Buy |
3 Apr ‘23
2 years ago |
|
93
Artelo Biosciences
ARTL
$6.01M
|
MH
Michael Higgins
| $4.55 | $360 |
7,812%
upside
| Buy |
3 Apr ‘23
2 years ago |
|
94
Venus Concept
VERO
$4.18M
|
JC
Jeffrey Cohen
| $2.25 | $363 |
16,033%
upside
| Buy |
28 Mar ‘23
2 years ago |
|
95
Essential Properties Realty Trust
EPRT
$6.04B
|
JM
John Massocca
| $30.46 | $27 |
11%
downside
| Buy |
23 Mar ‘23
2 years ago |
|
96
Adverum Biotechnologies
ADVM
$74.3M
|
AH
Aydin Huseynov
| $3.54 | $20 |
465%
upside
| Buy |
7 Mar ‘23
2 years ago |
|
97
Rhythm Pharmaceuticals
RYTM
$6.63B
|
MH
Michael Higgins
| $99.77 | $35 |
65%
downside
| Buy |
2 Mar ‘23
2 years ago |
|
|
ADAM
98
Adamas Trust, Inc. Common Stock
ADAM
$659M
|
CN
Christopher Nolan
| $7.30 | $12 |
64%
upside
| Neutral |
24 Feb ‘23
2 years ago |
|
99
Kiora Pharmaceuticals
KPRX
$9.24M
|
MK
Matthew Kaplan
| $2.69 | $1,071 |
39,714%
upside
| Buy |
8 Feb ‘23
2 years ago |
|
|
MTVA
100
MetaVia Inc. Common Stock
MTVA
$16.7M
|
AH
Aydin Huseynov
| $0.6901 | $48 |
6,856%
upside
| Buy |
7 Dec ‘22
2 years ago |
|